TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2026)

TransMedics (TMDX) posted Total Non-Current Liabilities of $942.4 million for Q2 2026, up 0.59% on a QoQ basis from $936.8 million in Q1 2026.

Analysis

TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

TransMedics has reported Total Non-Current Liabilities for 3 years, with the latest figure at $942.4 million in Q2 2026.

On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $942.4 million in Q2 2026; TTM through Jun 2026 was $942.4 million, a N/A change from a year earlier, with the FY2022 full-year figure at $89.8 million, changed N/A from the prior year.
Total Non-Current Liabilities was $942.4 million for Q2 2026 at TransMedics, up from $936.8 million in the prior quarter.
The five-year high for Total Non-Current Liabilities was $942.4 million in Q2 2026, with the low at $89.8 million in Q4 2022.
Average Total Non-Current Liabilities over 3 years is $528.6 million, with a median of $554.0 million recorded in 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	-
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	1.92 Bn
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	40.46 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	21.28 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	17.56 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	2.57 Bn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	6.34 Bn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	3.68 Bn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	3.44 Bn
10	TransMedics	2.98 Bn	2.51 Bn	113.20 Mn	942.36 Mn

Historic Data

Download Data